Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001855763-24-000011

Secretary acquired 2,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Carle Vanessa · Secretary

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-14 Exercise or conversion : show line 1 in the form +2,500 $1.15 $2,875 2,567 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-14 Exercise or conversion : show line 2 in the form Stock Options −2,500 60,067 D
Loading xslF345X05/primary_doc.xml…